Spectral Medical Inc. (OTCMKTS:EDTXF – Get Free Report) was the target of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 86,600 shares, a growth of 12.3% from the May 31st total of 77,100 shares. Based on an average trading volume of 10,700 shares, the short-interest ratio is currently 8.1 days.
Spectral Medical Stock Performance
EDTXF stock opened at $0.36 on Wednesday. The company has a market capitalization of $100.10 million, a PE ratio of -7.14 and a beta of 0.93. Spectral Medical has a one year low of $0.22 and a one year high of $0.50. The company’s 50 day moving average price is $0.36 and its two-hundred day moving average price is $0.36.
Spectral Medical (OTCMKTS:EDTXF – Get Free Report) last released its quarterly earnings data on Monday, May 13th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.50 million during the quarter.
About Spectral Medical
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
Featured Articles
- Five stocks we like better than Spectral Medical
- What Are Growth Stocks and Investing in Them
- RXO Shares Surge Following New Acquisition Deal
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.